www.lithium-stocks.net is pleased to announce its HOT Watch List! We encourage investors to join the FREE daily netmail alerts by visiting: http://lithium-stocks.com/dada/mail AMEL, AmeriLithium Corp., AMEL.OB AMEL is a mining company attached to progressively developing into one of the leading American players in the global Lithium industry.
Follow @StocksOnAlert For Up To Date Information On This Company!
** Edit this text AMEL reports its finally got its second withdraw from the$10 million finance agreement on April 29, 2010 to accelerate AMEL’s ongoing US exploration program on its Paymaster Project in Nevada.
Their main project is a 5.8k acre claim rite becide Clayton Valley , where lithium-rich liquid is evaporated and accumulating lithium for over 30 thousand years. This is the highest lithium contend in any of the US that has been surveyed to date.
Furthermore: – AMEL recently executed a definitive agreement thereby acquiring 100% of the assets of the 5,280-acre (8.25 square mile) Clayton Deep Lithium brine project, covering the entire Southwest Gravity Low in Clayton Valley, NV.
- AMEL recently executed a definitive agreement thereby acquiring 100% of the assets of the 5,760-acre (9 square mile) Full Monty project in Nye County, NV. The federal placer mining claims lie 25 miles north of Clayton Valley’s prime Lithium-mining region.
PWRM, Power 3 Medical Products (PWRM 0.061 ↓12.77%) Inc., PWRM.OB Stem cell treatments are a type of genetic medicine that introduce new cells into damaged tissue in order to treat a disease or injury.
A lot of DM medical people say that stem cell treatments can change the face of human disease and alleviate suffering. The ability of stem cells to self-renew and give rise to subsequent generations that can differentiate, offers a large potential to culture tissues that can replace diseased and damaged tissues in the body, without the risk of rejection and side effects.
PWRM is a leader in bio-medical research and the commercialization of biomarkers , tests, and mechanisms of disease. PWRM’s development of its screening and diagnostic testing for early drug detection is a new technology that is still patent-pending identify protein biomarkers, and drug targets, fulfilling serious unmet needs and challenges in areas like: neurodegenerative diseases and breast cancer. ).
Last February, PWRM entered into a definitive merger agreement to acquire StemTroniX, Inc.
StemTroniX, Inc. is a stem cell biotechnology acquisition and holding company that is committed to improving the lives of individuals by using autologous adult stem cell technology to repair tissue damage in patients.
Autologous adult stem cell therapy is the process of using an individual’s own stem cells for the purpose of repairing and regenerating damaged tissue. StemTroniX also provides a patented system to augment this process in a non-invasive method for in-body monitoring of the stem cells at the site of injury as they are being introduced into the patients.
Check Out http://www.lithium-stocks.net For More stories like this, Plus all the lithium market information relevant to investors and market guys.
